Compounds synthesized within the CC4CARB program will be tested by NIAID under a separate contract for the minimum inhibitory concentrations (MICs) against select drug-resistant and wild type strains of Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, and Neisseria gonorrhoeae.
If you wish to discuss your submission with an RTI team member, please email the project email address at CC4CARB@rti.org or call (833) 870-0484.
RTI shall preserve the confidentiality of proposals submitted to the center except where disclosure is required by law (Freedom of Information Act); however, compounds made from proposals submitted under CC4CARB will be publicly disclosed. See Proposal Confidentiality Policy.
The Chemistry Center for Combating Antibiotic Resistant Bacteria (CC4CARB) is a NIH NIAID lead initiative
contracted with RTI International. CC4CARB is a free service completely supported by NIH NIAID.